Detalles de la búsqueda
1.
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Cancer Immunol Immunother
; 70(6): 1667-1678, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33315149
2.
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Oncologist
; 25(10): 886-893, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353192
3.
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
Br J Cancer
; 118(6): 820-824, 2018 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29509748
4.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028664
5.
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
Int J Cancer
; 139(4): 938-45, 2016 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27038273
6.
Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients.
Oncology
; 91(6): 311-316, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27705972
7.
Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literature.
Future Oncol
; 12(7): 901-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26883177
8.
Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer.
Cancers (Basel)
; 13(15)2021 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359727
9.
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients.
J Thorac Dis
; 13(11): 6373-6380, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992817
10.
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab.
Expert Opin Biol Ther
; 20(3): 319-326, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011207
11.
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.
Adv Ther
; 37(3): 1145-1155, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002809
12.
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study.
Cancers (Basel)
; 11(7)2019 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31277449
13.
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
Clin Colorectal Cancer
; 18(4): e394-e401, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564556
14.
C-MET inhibitors for advanced non-small cell lung cancer.
Expert Opin Investig Drugs
; 27(4): 363-375, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29621416
15.
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Cancer Biomark
; 21(3): 731-741, 2018 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29278885
16.
Seabed litter composition, distribution and sources in the Northern and Central Adriatic Sea (Mediterranean).
Waste Manag
; 58: 41-51, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27614560
17.
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data.
J Exp Clin Cancer Res
; 34: 156, 2015 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26693938
Resultados
1 -
17
de 17
1
Próxima >
>>